Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 while Breastfeeding
Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50.

What is Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 used for?


▪helps prevent sunburn ▪if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Purpose: Active ingredients Purpose Homosalate 10% Octinoxate 7.5% Titanium dioxide 3.15% Sunscreen Sunscreen Sunscreen Zinc oxide 5% Sunscreen

Is Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 high risk while breastfeeding
There are total 4 active ingredients in Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 which makes it a complicated task to assess the effect of Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 on breastfeeding. Here on drlact after analyzing all 4 ingredients we have reached on conclusion that Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 is unsafe in breastfeeding. Below is our summarized analysis of Homosalate, Octinoxate, Titanium dioxide, Zinc oxide.

Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 Breastfeeding Analsys


Zinc oxide while Breastfeeding

Safe

CAS Number: 1314-13-2

It is used topically as an astringent and skin protector, very often together with small amounts of Ferric Oxide to form Calamine (see specific info). It is a product compatible with breastfeeding according to WHO Essential Medicine’s List - 2002.It is also used in dental hygiene products and cosmetics. Widely used for skin protection of the diaper area in infants. Because of the small dose used and poor absorption into plasma of most topical dermatological preparations, excretion into breastmilk in significant amount appears to be unlikely. Do not apply on the breast to prevent infant ingestion; otherwise, wash it off thoroughly with water before the next breast feed.


Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 Breastfeeding Analsys - 2


Homosalate and Breastfeeding

Unsafe

Homosalate has been found in mothers milk, its skin penetration rate is less than 1% in human and laboratory studies. Some studies suggest that Homosalate disrupts estrogen, androgen and progesterone levels. As not much study has been done on effects of Homosalate during breast feeding its recommended to use safe alternatives.

Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Homosalate passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (5001000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.


I already used Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 and meanwhile I breastfed my baby should I be concerned?

We have already established that Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 is unsafe in breastfeeding and breastfeeding while using Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My health care provider has asked me to use Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50, what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 then there must be good reason for that as Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Obagi Sun Shield Tint Cool Sunscreen Broad Spectrum Spf 50 in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

select id,x_fda_title from bsi_tab_fda_img where id in (2234,16334) limit 0,30

Drug Brands with same Active ingredients